Fellowship ProgrammeFellowship in Bone Marrow Transplant (BMT)Learn More & Apply ✦ Fellowship ProgrammeFellowship in Bone Marrow Transplant (BMT)Learn More & Apply
No file chosen
logo
Find a DoctorTechnologyContact UsCareerInternational PatientsHealth PackagesEvents
Haematology

Haematology Department: Expert Care for Blood Disorders and Blood Cancers

Blood disorders can be confusing-and often frightening - because symptoms may feel vague at first: fatigue, frequent infections, unusual bruising, heavy bleeding, or persistent fevers. A dedicated Haematology department brings together specialist doctors, advanced diagnostics, transfusion support, and evidence-based therapies to identify the cause quickly and start the right treatment without delay.

Haematology covers conditions involving red blood cells (anaemia and related disorders), white blood cells (immune and marrow conditions), platelets (bleeding/bruising disorders), and the clotting system. Leading centres clearly describe this full spectrum, from benign to malignant, in both adults and children.

When should you consult a haematologist?

You may be referred to Haematology after routine blood tests or when symptoms persist despite initial treatment. Importantly, a haematology referral does not automatically mean cancer; many referrals are for treatable deficiencies, inherited disorders, immune conditions, or clotting problems.

Common reasons for referral include:

  • Persistent anaemia (low haemoglobin), fatigue, weakness, shortness of breath
  • Recurrent fever/infections or abnormal white cell counts
  • Easy bruising, nosebleeds, gum bleeding, heavy menstrual bleeding, or low platelets
  • Unexplained blood clots (DVT/PE) or abnormal clotting tests
  • Enlarged lymph nodes, unexplained weight loss, night sweats (needs specialist evaluation)

Competitor education pages often describe these patterns as “increase or decrease in blood components” and link them to anaemia, infections, or bleeding/clotting risks. Patients understand this framing quickly.

Conditions we diagnose and treat

Benign (non-cancerous) blood disorders

  • Anaemia (nutritional deficiencies, chronic disease, haemolysis)
  • Thalassemia and other inherited haemoglobin disorders
  • Sickle cell disease and related haemoglobinopathies
  • Immune thrombocytopenia (ITP) and other platelet disorders
  • Haemophilia and bleeding disorders
  • Polycythemia and elevated blood counts
  • Clotting disorders and thrombosis (DVT and arterial thromboembolism)

Sarvodaya’s clinical list is helpful because it shows the range, from haemophilia and thalassemia to thrombosis and sepsis, demonstrating that haematology is not “only cancer.”

Blood cancers and bone marrow disorders (Haemato-Oncology)

Blood cancers generally arise in the bone marrow or immune system and can affect normal blood formation. Many competitor pages introduce patients to the key categories: leukaemia, lymphoma, and myeloma.

We evaluate and manage:

  • Leukaemias (acute and chronic)
  • Lymphomas (Hodgkin and Non-Hodgkin)
  • Multiple myeloma and plasma cell disorders
  • Bone marrow failure syndromes, aplastic anaemia, and related conditions

For complex blood cancers, haemato-oncology care typically involves a multidisciplinary approach: medical oncology, radiation oncology (where indicated), transfusion medicine, infection control, and supportive services. Competitor cancer centres emphasise this integrated model, especially for transplant pathways.

Advanced diagnostics under one roof

Accurate diagnosis in haematology depends on combining clinical assessment with high-quality laboratory evaluation. Some hospitals explicitly separate haematology into two aspects-clinical management and laboratory diagnosis-and that’s exactly how a strong service should function day to day.

Our diagnostic capabilities commonly include:

  • Complete blood count (CBC) with peripheral smear review
  • Bone marrow aspiration and biopsy when indicated
  • Haemoglobin electrophoresis to identify haemoglobin disorders such as thalassemia or sickle cell disease
  • HLA testing for transplant matching and planning
  • Advanced imaging support (CT/PET when clinically appropriate)

Treatment approach: personalised, evidence-based, and supportive

Haematology treatment isn’t only about prescribing medicines-it’s about building a plan that balances effectiveness, safety, and quality of life, while monitoring results closely and adjusting quickly.

Depending on your condition, care may include:

  • Targeted therapies, immunotherapy, or chemotherapy (for selected malignancies)
  • Iron, B12, folate, or other deficiency correction
  • Transfusion support (RBC/platelets) and clotting factor replacement when needed
  • Management of infections and immune complications
  • Long-term follow-up for inherited blood disorders

Leading haemato-oncology services also highlight patient monitoring and plan adjustments as treatment progresses, which is a key trust signal for patients and caregivers.

Bone Marrow / Stem Cell Transplant (BMT): when specialised care matters most

A bone marrow (stem cell) transplant is a procedure in which healthy blood-forming stem cells are infused into the marrow to restore its function. International medical sources describe two major categories:

 

  • Autologous transplant (your own stem cells)
  • Allogeneic transplant (donor stem cells)

Competitor BMT pages in India also call out additional transplant options (such as matched related/unrelated donors and haploidentical transplants) and emphasise infection-controlled environments and multidisciplinary support-these are real differentiators patients should look for.

A transplant pathway typically includes:

  • Eligibility assessment (blood tests, imaging, marrow studies)
  • Donor matching and HLA testing
  • Conditioning therapy and supportive care
  • Stem cell infusion and close monitoring
  • Recovery, infection prevention, and long-term follow-up

What makes a strong haematology centre?

When you compare competitor positioning across NCR/India, the most persuasive service pages consistently underline the same pillars:

  • Comprehensive scope: benign + malignant disorders; adults + paediatrics
  • Integrated lab strength: fast, reliable diagnostics and transfusion support
  • Multidisciplinary care: haematology + oncology + infection care + nutrition + counselling for complex journeys like BMT
  • Family and caregiver support: financial counselling, psychological support, and structured follow-up

Your first visit: what to bring and what to expect

To help your consultation be more productive, bring:

  • Past CBC reports and any bone marrow/lab reports (if done)
  • Current medication list and transfusion history
  • Family history of blood disorders (thalassemia, sickle cell, bleeding disorders)
  • A note of symptoms and timeline (fatigue, fevers, bruising, bleeding)

After clinical evaluation, your haematologist may recommend targeted tests and explain the results, what is urgent vs. watchful monitoring, and the next steps.

Get a call back from our
Health expert

IN+91

Email - info@shardacare.com

Your privacy is our priority. Your information is kept secure and confidential.

Looking for an Expert

ShardaCare – Healthcity is home to some of the most eminent doctors in the world.

Book an Appointment

Our Medical Experts

Dr. Pawan Kumar Singh

Dr. Pawan Kumar Singh

Vice Chairman - (Haemato-Oncology & BMT)


Institute of BMT & Haematology

Experience: 15+ Years
  • All BLOOD-RELATED disorders

  • Leukemia, lymphoma, and multiple myeloma

  • High-dose and induction chemotherapy (AML, ALL, MPAL)

  • Targeted and immunotherapies in hematologic malignancies

  • Allogeneic bone marrow transplantation (MSD, MUD, Haplo)

  • Aplastic anemia and bone marrow failure syndromes

  • High-risk and complex transplant cases

  • Bone marrow transplantation in special clinical scenarios (Jehovah’s Witness patients, HIV, viral infections, CKD on dialysis)

  • Thalassemia and sickle cell disease

  • Autologous BMT for autoimmune diseases, especially multiple sclerosis

  • Graft manipulation and T-cell–depleted haploidentical BMT

  • CAR-T cell therapy

Dr. Isha

Dr. Isha

Associate Consultant - (Haemato-Oncology & BMT)


Institute of BMT & Haematology

Experience: 7+ Years
  • Leukemia, lymphoma & myeloma Treatment

  • AML/All Induction Chemotherapy

  • Targeted Therapies & Immunotherapies

  • Hodgkin & Non-Hodgkin Lymphoma

  • Allogenic BMT: MSD, MUD, Haplo

  • Aplastic Anemia, Thalassemia, Sickle Cell Disease

  • Autologous BMT in Autoimmune Diseases: Especially Multiple Sclerosis